Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase

被引:0
作者
X Wang
G P Doherty
M K Leith
T J Curphey
A Begleiter
机构
[1] Manitoba Institute of Cell Biology,Departments of Pharmacology and Therapeutics
[2] Manitoba Cancer Treatment and Research Foundation,Departments of Internal Medicine
[3] University of Manitoba,Department of Pathology
[4] University of Manitoba,undefined
[5] University of Manitoba,undefined
[6] Dartmouth College,undefined
来源
British Journal of Cancer | 1999年 / 80卷
关键词
mitomycin C; DT-diaphorase; cytotoxicity; enzyme inducers;
D O I
暂无
中图分类号
学科分类号
摘要
DT-diaphorase is a two-electron reducing enzyme that activates the bioreductive anti-tumour agent, mitomycin C (MMC). Cell lines having elevated levels of DT-diaphorase are generally more sensitive to MMC. We have shown that DT-diaphorase can be induced in human tumour cells by a number of compounds, including 1,2-dithiole-3-thione. In this study, we investigated whether induction of DT-diaphorase could enhance the cytotoxic activity of MMC in six human tumour cell lines representing four tumour types. DT-diaphorase was induced by many dietary inducers, including propyl gallate, dimethyl maleate, dimethyl fumarate and sulforaphane. The cytotoxicity of MMC was significantly increased in four tumour lines with the increase ranging from 1.4- to threefold. In contrast, MMC activity was not increased in SK-MEL-28 human melanoma cells and AGS human gastric cancer cells, cell lines that have high base levels of DT-diaphorase activity. Toxicity to normal human marrow cells was increased by 50% when MMC was combined with 1,2-dithiole-3-thione, but this increase was small in comparison with the threefold increase in cytotoxicity to tumour cells. This study demonstrates that induction of DT-diaphorase can increase the cytotoxic activity of MMC in human tumour cell lines, and suggests that it may be possible to use non-toxic inducers of DT-diaphorase to enhance the efficacy of bioreductive anti-tumour agents.
引用
收藏
页码:1223 / 1230
页数:7
相关论文
共 242 条
[1]  
Adams GE(1994)Bioreductive drugs for cancer therapy: the search for tumor specificity Int J Radiat Oncol Biol Phys 29 231-238
[2]  
Stratford IJ(1997)Soy feeding induces phase II enzymes in rat tissues Nutr Cancer 28 270-275
[3]  
Appelt LC(1996)Development and validation of a spectrophotometric assay for measuring the activity of NADH:cytochrome b5 reductase in human tumour cells Br J Cancer 74 1188-1193
[4]  
Reicks MM(1995)Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumour quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines Mol Pharmacol 48 499-504
[5]  
Barham HM(1996)Role of NAD(P)H:quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin Biochem Pharmacol 51 645-652
[6]  
Inglis R(1997)Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma Ann Oncol 8 363-367
[7]  
Chinje EC(1989)Increased sensitivity of quinone resistant cells to mitomycin C Cancer Lett 45 173-176
[8]  
Stratford IJ(1992)The role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia Mol Pharmacol 41 677-683
[9]  
Beall HD(1995)Comparison of antitumor activities of 2-chlorodeoxyadenosine and 9-β-arabinosyl-2-fluoroadenine in chronic lymphocytic leukemia and marrow cells in vitro Leukemia 9 1875-1881
[10]  
Murphey AM(1996)Induction of DT-diaphorase by 1,2-dithiole-3-thione and increase of antitumour activity of bioreductive agents Br J Cancer 74 S9-S14